US 6468983
RNase L activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies
expired A61KA61K38/00A61P
Quick answer
US patent 6468983 (RNase L activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K38/00, A61P, A61P35/00, A61P43/00